fagaronine has been researched along with ethoxidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alix, AJ; Devy, J; Duval, O; Fleury, F; Ianoul, A; Jardillier, JC; Kudelina, I; Nabiev, I; Sukhanova, A | 1 |
| Devy, J; Duval, O; Lynch, MA; MacKay, SP; Nabiev, I; Sukhanova, A; Waigh, RD | 1 |
| Anthony, NG; Clark, RL; Deane, FM; Johnston, BF; Mackay, SP; McCarthy, FO | 1 |
3 other study(ies) available for fagaronine and ethoxidine
| Article | Year |
|---|---|
Molecular determinants of site-specific inhibition of human DNA topoisomerase I by fagaronine and ethoxidine. Relation to DNA binding.
Topics: Alkaloids; Antineoplastic Agents; Base Sequence; Benzophenanthridines; Binding Sites; DNA Topoisomerases, Type I; Enzyme Inhibitors; Humans; Molecular Sequence Data; Phenanthridines; Substrate Specificity; Topoisomerase I Inhibitors | 2000 |
Synthesis, biological activity and comparative analysis of DNA binding affinities and human DNA topoisomerase I inhibitory activities of novel 12-alkoxy-benzo[c]phenanthridinium salts.
Topics: Alkaloids; Alkanes; Antineoplastic Agents; Benzophenanthridines; DNA; DNA Topoisomerases, Type I; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Phenanthridines; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2001 |
Exploring DNA topoisomerase I inhibition by the benzo[c]phenanthridines fagaronine and ethoxidine using steered molecular dynamics.
Topics: Alkaloids; Benzophenanthridines; Computer Simulation; DNA; DNA Topoisomerases, Type I; Enzyme Inhibitors; Ligands; Models, Molecular; Molecular Structure; Phenanthridines; Phenol; Phosphates; Topoisomerase I Inhibitors; Tyrosine | 2007 |